Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use.
Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Cormorant Asset Management has invested in 209 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cormorant Asset Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 15 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post Ipo Equity round. Cormorant Asset Management's total known invested capital is $25.0B.
Cormorant Asset Management's average investment size is $149.5M across its portfolio of 209 companies.
Recent Cormorant Asset Management portfolio additions include Kezar Life Sciences, Axonis Therapeutics, AgomAb Therapeutics, X4 Pharmaceuticals, Harpoon Therapeutics. These companies were founded in 2020 or later.